Tilray Inc (NASDAQ:TLRY – Get Free Report)’s share price dropped 1.2% during trading on Wednesday . The stock traded as low as $1.70 and last traded at $1.70. Approximately 5,578,038 shares traded hands during trading, a decline of 78% from the average daily volume of 25,032,898 shares. The stock had previously closed at $1.72.
Tilray Trading Down 2.0 %
The firm has a 50-day moving average of $1.81 and a 200-day moving average of $1.88. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.42 and a current ratio of 2.27. The firm has a market capitalization of $1.42 billion, a P/E ratio of -3.86 and a beta of 2.13.
Tilray (NASDAQ:TLRY – Get Free Report) last released its quarterly earnings data on Monday, July 29th. The company reported ($0.04) earnings per share for the quarter, missing the consensus estimate of ($0.02) by ($0.02). The business had revenue of $229.90 million during the quarter, compared to analysts’ expectations of $226.20 million. Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The company’s quarterly revenue was up 24.8% compared to the same quarter last year. During the same quarter last year, the business posted ($0.15) EPS. On average, equities research analysts anticipate that Tilray Inc will post -0.16 EPS for the current fiscal year.
Institutional Trading of Tilray
Tilray Company Profile
Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Nanaimo, Canada.
Recommended Stories
- Five stocks we like better than Tilray
- Best Stocks Under $10.00
- Should You Invest in Treasury Bills?
- 3 Warren Buffett Stocks to Buy Now
- Analysts Think There’s Still Time to Get in on Edgewise, Up 332%
- Where Do I Find 52-Week Highs and Lows?
- 3 Stocks Raising Dividends 4X Higher Than Inflation
Receive News & Ratings for Tilray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tilray and related companies with MarketBeat.com's FREE daily email newsletter.